Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

50.200
+4.60010.09%
Volume:13.48M
Turnover:655.49M
Market Cap:333.18B
PE:36.43
High:50.400
Open:46.080
Low:45.380
Close:45.600
52wk High:94.869
52wk Low:43.020
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:5.00
T/O Rate:5.22%
Dividend:0.23
Dividend Rate:0.47%
EPS(LYR):1.378
ROE:12.46%
ROA:7.02%
PB:4.43
PE(LYR):36.43
PS:9.11

Loading ...

HENGRUI PHARMA: UBS Group AG Acquires Shares, Long Position Rises to 5.23%

HK Disclosure
·
Sep 25

HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.32%

HK Disclosure
·
Sep 25

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.7%

HK Disclosure
·
Sep 24

HENGRUI PHARMA: GIC Private Limited Disposes of Shares, Long Position Falls to 16.92%

HK Disclosure
·
Sep 24

Movement Alert|HENGRUI PHARMA Falls 3.01% in Regular Trading, Pharmaceuticals Sector Under Broad Selling Pressure

Market Focus
·
Sep 24

HENGRUI PHARMA Spends RMB 11.37 Million Buying Back 250,000 A-Shares on September 23

Stock News
·
Sep 23

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approvals for Ten Drug Candidates

Stock News
·
Sep 23

Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug

MT Newswires Live
·
Sep 22

Hengrui Pharmaceuticals Gets China Approval for Tumor Drug Trial

MT Newswires Live
·
Sep 22

Hengrui Pharma's Unit Gets Nod to Trial HRS-1596 Tablets; Shares Down 3%

MT Newswires Live
·
Sep 22

Movement Alert|HENGRUI PHARMA Falls 3.04% in Regular Trading, Pulling Back After Prior Sessions Strong Rally Amid Broad Sector Weakness

Market Focus
·
Sep 22

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approval for SHR-4595 Injection

Stock News
·
Sep 21

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Stock News
·
Sep 21

Movement Alert|HENGRUI PHARMA Rises 3.11% in Regular Trading, Buyback Launched and Employee Stock Plan Unveiled Amid BlackRock Accumulation

Market Focus
·
Sep 21

HENGRUI PHARMA: BlackRock, Inc. Disposes, Long Position Falls to 6.99%

HK Disclosure
·
Sep 18

Hong Kong Stock Market Update | Hengrui Pharma Surges Nearly 4% on First A-Share Buyback as Analysts Eye Growth in Non-Oncology Portfolio

Stock News
·
Sep 18

Movement Alert|HENGRUI PHARMA Rises 3.78% in Regular Trading, First A-Share Buyback Executed as BlackRock Raises Stake to 7.68%

Market Focus
·
Sep 18

Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.68% on Sept 14, HKEX Filing Shows

Reuters
·
Sep 17

Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital

Bulletin Express
·
Sep 17

Jiangsu Hengrui Pharmaceuticals Completes Initial Share Repurchase, Investing 14.5 Million Yuan

Stock News
·
Sep 17